GR78313B - - Google Patents

Info

Publication number
GR78313B
GR78313B GR71726A GR830171726A GR78313B GR 78313 B GR78313 B GR 78313B GR 71726 A GR71726 A GR 71726A GR 830171726 A GR830171726 A GR 830171726A GR 78313 B GR78313 B GR 78313B
Authority
GR
Greece
Application number
GR71726A
Inventor
D R Maxwell
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of GR78313B publication Critical patent/GR78313B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
GR71726A 1982-06-22 1983-06-20 GR78313B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/391,198 US4452798A (en) 1982-06-22 1982-06-22 1-Substituted phenyl-4-alkyl hydantoin piperazine compounds as antihypertensive agents

Publications (1)

Publication Number Publication Date
GR78313B true GR78313B (el) 1984-09-26

Family

ID=23545665

Family Applications (1)

Application Number Title Priority Date Filing Date
GR71726A GR78313B (el) 1982-06-22 1983-06-20

Country Status (17)

Country Link
US (1) US4452798A (el)
EP (1) EP0103357A3 (el)
JP (1) JPS5925376A (el)
KR (1) KR840005726A (el)
AU (1) AU537383B2 (el)
CA (1) CA1204754A (el)
DK (1) DK285683A (el)
ES (2) ES8504776A1 (el)
FI (1) FI832241L (el)
GR (1) GR78313B (el)
HU (1) HU187941B (el)
IL (1) IL68942A (el)
NO (1) NO832254L (el)
NZ (1) NZ204658A (el)
PH (1) PH18302A (el)
PT (1) PT76899B (el)
ZA (1) ZA834500B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114027A (en) 1994-06-08 1999-11-30 Lundbeck & Co As H 4-Phenyl piperazine (piperidine or tetrahydropyridine) derivatives serotinin 5-HT1A and dopamin D2 receptor ligand pharmaceutical compositions containing them
US6083950A (en) * 1997-11-13 2000-07-04 Ranbaxy Laboratories Limited 1-(4-arylpiperazin-1-yl)-ω-[n-(α,ω-dicarboximido)]-alka nes useful as uro-selective α1-adrenoceptor blockers
CA2338317A1 (en) * 1998-07-21 2000-02-03 Ranbaxy Laboratories Limited Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers
AU1979799A (en) * 1998-07-21 2000-02-14 Ranbaxy Laboratories Limited Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2836595A (en) * 1958-05-27 Piperazine derivatives and process for
US3037024A (en) * 1962-05-29 Chjchj
FR1012751A (fr) * 1949-01-24 1952-07-17 Rhone Poulenc Sa Nouveau dérivé de la pipérazine et de la quinoléïne et son procédé de préparation
ES291187A1 (es) * 1963-04-04 1964-01-16 American Cyanamid Co Un procedimiento para preparar piperazinas sustituidas
DE1445547C3 (de) * 1964-10-13 1975-04-30 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von 3-Amino-2,1-benzoisothiazolen
US3494932A (en) * 1967-06-26 1970-02-10 American Cyanamid Co Aminoalkyl substituted aryl hydantoins
US3576808A (en) * 1967-09-15 1971-04-27 Miles Lab N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones
BE788280A (fr) * 1971-09-04 1973-02-28 Pfizer Nouvelles 1-(3-trifluoro-methyl-phenyl)-4-((amido cyclique)- alkyl) piperazines et composition pharmaceutique les contenant
US3806510A (en) * 1972-09-18 1974-04-23 Parke Davis & Co 4(orthoalkylthio phenyl)piperazin-1-yl hydantoins
US4038279A (en) * 1972-12-23 1977-07-26 Boehringer Ingelheim Gmbh N-aryl-n'-(phenyl-or phenoxy-alkyl)-piperazines and salts thereof
DE2263211A1 (de) * 1972-12-23 1974-07-04 Boehringer Sohn Ingelheim Neue arylpiperazine und verfahren zu ihrer herstellung
GB1443598A (en) * 1973-07-06 1976-07-21 Acraf 1- 3-acetylaminopropyl-4-2,5-dichlorophenyl-piperazine
US3892748A (en) * 1973-07-20 1975-07-01 Miles Lab 5,5-Diphenyl-3-(piperidino, tetrahydropyridyl-1-and piperazino)-hydantoins
US3879395A (en) * 1973-10-23 1975-04-22 Parke Davis & Co 3-(1-Piperazinylalkylamino)-2-cycloalken-1-one compounds and methods for their production
FR2306694A1 (fr) * 1975-04-07 1976-11-05 Parcor Derives de la piperazine
BE503170A (el) * 1975-09-02

Also Published As

Publication number Publication date
US4452798A (en) 1984-06-05
PT76899A (en) 1983-07-01
EP0103357A3 (en) 1986-01-08
DK285683A (da) 1983-12-23
EP0103357A2 (en) 1984-03-21
HU187941B (en) 1986-03-28
FI832241L (fi) 1983-12-23
ZA834500B (en) 1984-03-28
PH18302A (en) 1985-05-29
FI832241A0 (fi) 1983-06-20
ES523462A0 (es) 1985-04-16
CA1204754A (en) 1986-05-20
IL68942A0 (en) 1983-10-31
NZ204658A (en) 1985-12-13
DK285683D0 (da) 1983-06-21
IL68942A (en) 1987-02-27
PT76899B (en) 1986-01-24
KR840005726A (ko) 1984-11-16
NO832254L (no) 1983-12-23
ES8504776A1 (es) 1985-04-16
ES537961A0 (es) 1985-11-01
ES8601948A1 (es) 1985-11-01
JPS5925376A (ja) 1984-02-09
AU537383B2 (en) 1984-06-21
AU1565883A (en) 1984-01-05

Similar Documents

Publication Publication Date Title
FR2523438B1 (el)
FR2523892B1 (el)
FR2522769B1 (el)
FR2519301B1 (el)
DE3318968C2 (el)
FR2523200B1 (el)
DE3302502C2 (el)
FR2524908B1 (el)
FR2522723B1 (el)
DE3228198C2 (el)
DE3326082C2 (el)
DE3242346C2 (el)
FR2520073B1 (el)
FR2522284B1 (el)
FR2523010B1 (el)
FR2523395B1 (el)
DE3205524C2 (el)
FR2523274B1 (el)
FR2521310B3 (el)
FR2522217B1 (el)
GR78313B (el)
DE8221839U1 (el)
FR2520460B1 (el)
FR2521822B1 (el)
DE8210186U1 (el)